- Home
- VERI vs SNTI Comparison
VERI vs SNTI Comparison
Compare VERI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERI
- SNTI
- Stock Information
- Founded
- VERI 2014
- SNTI 2016
- Country
- VERI United States
- SNTI United States
- Employees
- VERI 487
- SNTI N/A
- Industry
- VERI EDP Services
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- VERI Technology
- SNTI Health Care
- Exchange
- VERI Nasdaq
- SNTI Nasdaq
- Market Cap
- VERI 91.5M
- SNTI 85.3M
- IPO Year
- VERI 2017
- SNTI N/A
- Fundamental
- Price
- VERI $1.81
- SNTI $3.26
- Analyst Decision
- VERI Strong Buy
- SNTI Strong Buy
- Analyst Count
- VERI 2
- SNTI 1
- Target Price
- VERI $5.25
- SNTI $12.00
- AVG Volume (30 Days)
- VERI 442.4K
- SNTI 226.1K
- Earning Date
- VERI 05-08-2025
- SNTI 05-06-2025
- Dividend Yield
- VERI N/A
- SNTI N/A
- EPS Growth
- VERI N/A
- SNTI N/A
- EPS
- VERI N/A
- SNTI N/A
- Revenue
- VERI $90,937,000.00
- SNTI N/A
- Revenue This Year
- VERI $23.41
- SNTI N/A
- Revenue Next Year
- VERI $26.79
- SNTI N/A
- P/E Ratio
- VERI N/A
- SNTI N/A
- Revenue Growth
- VERI N/A
- SNTI N/A
- 52 Week Low
- VERI $1.86
- SNTI $1.52
- 52 Week High
- VERI $5.64
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- VERI 35.04
- SNTI 44.18
- Support Level
- VERI $1.94
- SNTI $3.10
- Resistance Level
- VERI $2.05
- SNTI $3.47
- Average True Range (ATR)
- VERI 0.12
- SNTI 0.42
- MACD
- VERI -0.01
- SNTI -0.07
- Stochastic Oscillator
- VERI 6.90
- SNTI 16.74
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.